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Introduction Chronic kidney disease (CKD) has emerged as a major medical illness that 
drew the attention of the community. This research focused on the prevalence 
of five contributing factors to the progression of CKD, namely blood pressure 
control, glycaemic control, lipid control, smoking and alcohol intake, and 
explored significant association between these variables. This was a cross-
sectional study that examined the progression of CKD based on the 
worsening of CKD stages.
Methods This study was conducted among CKD patients with type 2 diabetes mellitus 
who attended Nephorology Clinic, UKMMC from April to May 2011. The 
progression of CKD was observed for 3 consecutive visits with 3 months 
intervals between the visits. Information regarding demographic data and 
social history were obtained through face-to-face interview, followed by case 
note review of the blood results. Data collected was analysed using SPSS 
version 19.0.
Results A total of 201 respondents were investigated, which included 39.3% (n=79) 
female and 60.7% (n=122) male. The mean age for the respondents was 66.9 
years old (±SD 9.00). Among the respondents, 71.5% had poor glycaemic 
control; 59.7% had poor blood pressure control; 65.2% had poor lipid 
control; 19.9% smoked and 3.5% consumed alcohol. There was poor 
correlation, there were statistically significant association between systolic 
blood pressure control with the glomerular filtration rate (GFR) (p=0.001; r=-
0.229). From this research, high systolic blood pressure was associated with 
low GFR, which indicated poor kidney function and resulted in progression 
of CKD.
Conclusions This study has clearly demonstrated that the control of blood pressure was 
essential in delaying the progression of CKD.
Keywords Chronic kidney disease - disease progression - risk factors - type 2 diabetes 
mellitus - blood pressure
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INTRODUCTION
Chronic Kidney Disease (CKD) has emerged as a 
major medical problem and concern in the medical 
practices. It is related to various conditions or 
factors such as the underlying medical problems, 
management errors and the existing of unhealthy 
practices. This problem can only be curbed if an 
early detection and treatment are strengthened. 
CKD is defined according to the presence 
or absence of kidney damage or glomerular 
filtration rate (GFR) <60 mL/min/1.73 m2 for 3 
months or more, irrespective of cause. Kidney 
damage is defined as pathological abnormalities or 
markers of damage, including abnormalities in 
blood or urine tests or imaging studies. The 
glomerular filtration rate (GFR) can be estimated 
from calibrated serum creatinine and in this study;
the estimating equation used was Modifications of 
Diet in Renal Disease (MDRD) Study equation. 
There are five stages in the classification of CKD 
based on the level of GFR.1
There are many causes of CKD. One of 
the important ones is diabetes mellitus. In 
Malaysia, the number of diabetics has increased by 
almost 80 percent in the last 10 years from 1996-
2006.2 Nephropathy develops in about 20-40% of 
diabetics and the improvement of survival rates in 
diabetic patients; it has emerged as a major health 
problem. The sign of early diabetic nephropathy is 
the presence of microalbuminuria (albuminuria 30-
300 mg/day). This progresses to proteinuria 
(albuminuria > 300mg/day) and the decline in 
glomerular filtration rate (GFR).3 
Study has also shown that type 2 diabetes 
is the primary cause of end-stage renal disease 
(ESRD).4 Therefore, viable solutions such as early 
detection and control methods are urgently required 
to monitor and manage diabetes so that its 
progression towards CKD and finally ESRD could 
be slowed down.
An appropriate study is needed to explore 
the possible conditions or factors that facilitate the 
progression of CKD. Among the well-known 
factors which contribute to the progression of CKD 
are poor glycaemic control, hypertension, smoking, 
alcohol intake and hyperlipidaemia.  5,6,7,8,9,10 As 
there are not many studies done in Malaysia to 
understand this phenomena, this study examined all 
the possible factors that is responsible for the 
progression towards CKD and ESRD.
METHODS
This was a cross sectional study done in University 
Kebangsaan Malaysia Medical Centre. This 
research was approved by Research and Ethical 
Committee, Faculty of Medicine, Universiti 
Kebangsaan Malaysia (FF-126-2011).
There were 241 CKD patients with type 2 
diabetes mellitus who came for follow up at 
Nephrology Clinic in UKMMC during the study 
period (April 2011- May 2011). 
The sampling method adapted in this 
study was convenient sampling. The consent form 
was given to subjects to be filled up by them or 
their carers with the assistance of the researchers. 
The subject’s demographic data and background 
history were obtained and a brief interview with 
respondents in order to acquire the past medical 
history and lifestyle practices. This was followed 
by case note review in order to obtain the patient’s 
blood pressure, weight, HbA1c, serum lipid profile 
and renal profile on the latest 3 consecutive visits 
with an interval of 3 months. The progression of 
disease is determined by the worsening of stages of 
CKD based on GFR calculated from creatinine 
taken during the 3 consecutive visits. GFR was 
calculated by using Modification of Diet in Renal 
Disease (MDRD) equation which is
GFR= 186 x [(Serum Creatinine x 
0.0113) -1.154] x (age -0.203) x F
Where F = 1 if male, and 0.742 if female
Table 1 CKD staging.
Stage Description GFR Level mL/min
1 Kidney damage with normal or higher GFR > 90
2 Kidney damage and mild decrease in GFR 60 – 89
3 Moderate decrease in GFR 30 – 59
4 Severe decrease in GFR 15 – 29
5 Kidney failure (dialysis or kidney transplant needed) < 15
In this research, the independent variables 
studied were blood pressure, HbA1c, serum lipid 
profile, renal profile, history of smoking and 
alcohol intake. Pearson correlation was selected for 
data analysis and a p< 0.05 was considered 
significant.
Statistical analysis
All statistical analysis of the data was 
carried out using ‘Statistical Package for Social 
Science’ (SPSS) version 19. All parameters were 
normally distributed. The parametric analysis of 
five factors (control of blood pressure, glycaemic 
and lipid; significant smoking and alcohol intake) 
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was done using Chi square test. Pearson’s 
correlation was performed on continuous data of 
systolic blood pressure, diastolic blood pressure, 
HbA1c, triglycerides, cholesterol, cigarette pack-
years of smoking and number of drinks for alcohol. 
Except pack-years smoking and number of drinks 
for alcohol, other parameters were calculated from 
average of three readings. Between all continuous 
parameters and the latest GFR, Correlation test was 
used. P value of less than 0.05 was considered 
significant.
RESULTS
A total of 201 respondents participated in this 
study. Of these, 60.7% were male and 39.3% were 
female. The respondents’ age ranged from 34 to 87 
years old. Majority of the respondents were Malays 
(53.7%) whereas Chinese and Indians were 37.8% 
and 8.5% respectively. Majority of the respondents 
had low to moderate educational level and 86.1% 
were married. (Table 2)
The overall percentage of patients 
suffering CKD progression was 21.39% with male 
20.49% and female 22.78%. One out of five 
patients had worsening of their kidney function.  It 
is decreased with age from 38.8% (45-54 years old) 
to 15.38% (75-84years old). Among the Malays it 
was relatively higher at 23.1%, followed closely by 
Chinese 22.4% and Indian 5.9%. Others 
sociodemographic characteristics were summarized 
in Table 2.
There was high prevalence of poor control 
of medical parameters namely glycemia, blood 
pressure and lipid. Poor glycaemic control was 
71.5% whereas poor control of blood pressure and 
lipid is 83.1% and 65.2% respectively. 
Respondents who smoked significantly were 19.9% 
and 3.5% for significant alcoholic. Patients who 
smoke more than 10 cigarette pack-years classified 
as significant smoker whereby significant alcoholic 
means patients who consumed more than 15 drinks 
of alcohol weekly during the past year. (Table 3)
The proportion of CKD progression was
relatively higher among those with poor glycemic, 
blood pressure and lipid control compared to those 
with the good control. The similar finding was also 
noted among those who smoked significantly 
compared to those who did not. However its 
difference was not statistically significant.(Table 4)
Further analysis was carried out using 
Pearson’s correlation (Table 5). Latest GFR was 
used to correlate with average of three readings of 
HbA1c, systolic blood pressure, diastolic blood 
pressure, triglycerides and cholesterol. Quantity of 
smoking was represented by cigarette pack-years 
and alcohol intake by numbers of alcohol drinks. 
Although there was poor correlation, there was 
statistically significant association between systolic 
blood pressure control (p=0.001; r=-0.229) with the 
GFR (Figure 1). On the other hand, other 
parameters had no significant correlation with 
latest GFR.
Table 2 Sociodemographic background of study respondents (n=201).
            CKD    progression Mean±SD
Factors Characteristics Yes*=43 No=158
n(%) n(%)
Gender Male 25(20.5) 97(79.5)
Female 18(22.8) 61(77.2)
Age(in years) >85 1(50.0) 1(50.0) 66.9±9.00
75-84 6(15.4) 33(84.6)
65-74 13(15.3) 72(84.7)
55-64 16(29.1) 39(70.9)
45-54 7(38.9) 11(61.1)
<45 0(0.0) 2(100.0)
Race Malay 25(23.1) 83(76.9)
Chinese 17(22.4) 59(77.6)
Indian 1(5.9) 16(94.1)
Education None 5(13.9) 31(86.1)
Primary school 17(22.1) 60(77.9)
Secondary school 17(24.3) 53(75.7)
Pre-U/STPM 0(0.0) 5(100.0)
University/College 4(30.8) 9(69.2)
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Marital status Married 38(22.0) 135(78.0)
Divorced 0(0.0) 1(100.0)
Single 2(40.0) 3(60.0)
Widow/Widower 3(13.6) 19(86.4)
*Patients with CKD progression were those who showed worsening of CKD stages during their three latest 
follow-up in nephrology clinic, UKMMC
Table 3 Prevalence of various factors contributing to progression of CKD in type II diabetic patients
Factors Good Poor
Glycaemic control (n=201) 28.5%(n=57) 71.5%(n=144)
Blood pressure control(n=201) 16.9%(n=34) 83.1%(n=167)
Lipid control(n=201) 34.8%(n=70) 65.2%(n=131)
Not Significant Significant
Smoking(n=201)               80.1%(n=40)          19.9%(n=161)
Alcohol(n=201) 96.5%(n=194) 3.5%(n=7)
Table 4 Association between various factors and progression of CKD.
Factors CKD progression X2 p value
Yes (n=43) No (n=158)
f % f %
Glycaemic control
Poora 33 23.1 111 76.9 0.739 0.39
Good 10 17.5 47 82.5
Blood pressure control
Poorb 36 21.6 131 78.4 0.016 0.90
Good 7 20.6 27 79.4
Lipid control
Poorc 31 23.7 100 76.3 1.154 0.28
Good 12 17.1 58 82.9
Smoking
Significantd 11 27.5 29 72.5 1.108 0.29
Not significant 32 19.9 129 80.1
Alcohol intake
Significante 0 0.0 7 100.0 1.974 0.16
Not significant 43 22.2 151 77.8
a Poor glycaemic control is when the HbA1c is more than 6.5%
b Poor blood pressure control is when the blood pressure is higher than 130mmHg(systolic) or 80 
mmHg(diastolic).
c Poor serum lipid level control is when the total cholesterol exceeding 5.4mmol/L or triglycerides level 
exceeding 1.7mmol/L.
d Patients who smoke more than 10 cigarette pack-years. 
e Patients who consumed more than 15 drinks of alcohol weekly during the past year, whereby one drink defined 
by wine (5 oz or 148 ml), beer (12 oz or 355 ml), and liquor (1.5 oz or 44 ml).
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Table 5 Bivariate correlation between the parameters and latest GFR.
Parameters GFR
r p
HbA1c 0.027 0.7
Systolic blood pressure -0.229 0.001
Diastolic blood pressure -0.075 0.287
Triglycerides -0.027 0.708
Cholesterol -0.018 0.795
Cigarette pack-years -0.047 0.719
Number of alcohol drinks 0.335 0.127
Figure 1Scatter diagram shows correlation between systolic blood pressure and GFR.
DISCUSSION
High blood pressure has been well established to 
contribute to the pathology of disease, although our 
study failed to prove its role in the progression of 
CKD. Nevertheless, high systolic blood pressure 
was showed to be significantly correlated to low 
GFR, which indirectly depicts the importance of 
optimizing blood pressure control in CKD patients 
(p=0.001; r=-0.229). This result was supported by 
Marc A. Pohl et al in Irbesartan Diabetic 
Nephropathy Trial (IDNT), which also 
demonstrated presence of direct relationship 
between control of systolic BP and adverse renal 
outcomes among type 2 diabetic nephropathy 
patients, independent of baseline renal function.11
Moreover, our study reveals that there was high 
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prevalence of poor blood pressure control in CKD 
patient with type 2 diabetic patients (59.7%). 
Elevated systolic blood pressure was evidenced to 
be a risk factor in catalysing renal impairment 
among patients with type 2 diabetes.12 This 
indicated that an effective intervention in 
controlling blood pressure should be carried out in 
UKMMC.
The parameter used to determine 
glycaemic control in this study is glycated 
haemoglobin (HbA1c). Although there was no 
significant association between poor glycaemic 
control and CKD progression in our study which 
was in contrast to other study, the result was 
different in our study probably due to insufficient 
sample size and short duration of study.6 However, 
our study revealed that there was high prevalence 
of poor glycaemic control in CKD patients with 
type 2 diabetes (71.5%). These results indicated 
that some interventions need to be taken so that 
blood glucose can be controlled since several study
had stated that renal damage rarely occur when 
HbA1c is <7.5%13,14
The analysis results did not show any 
statistical significance between lipid control and 
progression of CKD. There were only 23.7% of 
respondents among poor lipid control that have 
progressive CKD. The result was not consistent 
with other studies probably due to the lipid profile 
of patients was calculated using the average of 
three laboratory investigation result in which some 
of the investigations were done many years ago. It 
may not give the true reflection of patients’ lipid 
control. However, there was a high prevalence of 
poor lipid control in CKD patient with type 2 
diabetic patients (65.2%). This figure drew our 
attention to improve patients’ lipid control. There 
was evidence that lipid reduction by antilipemic 
agents might preserve GFR and decrease the 
proteinuria in diabetic patients.14 Therefore, it is 
very crucial for patients to have a good lipid 
control.
Our study did not show any significant 
association between smoking with progression of 
CKD in type 2 diabetic patients. Among patients 
who had history of significant cigarette pack-years 
(≥ 10 pack-years), there were 27.5% of respondents 
with progression of CKD. Smoking had previously 
been associated with progression of CKD in 
various studies. In a study conducted by Telmer et 
al, prevalence of diabetic nephropathy was 
significantly higher among heavy smokers (>10 
cigarettes a day for more than one year) than 
among non-heavy smokers (p<0.02) which was in 
contrast to our study.16 Another study also 
demonstrated higher prevalence of nephropathy 
among patients who were or who had been 
cigarette smokers.17 A study showed no significant 
impact of smoking on the rate of decline in GFR 
when patients were stratified into smokers and 
nonsmokers. However, when patients were 
stratified into heavy smokers (smoking ≥20 
cigarettes a day) and non-heavy smokers (smoking 
≤19 cigarettes a day and nonsmokers), heavy 
smokers had showed a significantly greater rate of 
decline in GRF.4 In our study, we could not 
demonstrate a significant impact of smoking on the 
progression of CKD when patients were stratified 
into significant smokers (≥10 pack-years) and non-
significant smokers (≤9 pack-years or non-smoker). 
This probably due to insufficient sample size (only 
20% respondents are significant smoker) and short 
duration of study which failed to showed 
progression of CKD.
The result of this cross-sectional study did 
not show that alcohol intake is associated with an 
increase risk for CKD progression among patients 
with type 2 diabetes mellitus. There are relatively 
less studies done to demonstrate specifically the 
significance of alcohol intake in progression of 
either chronic renal disease or diabetic 
nephropathy. A case-control study done in several 
provinces of United States depicted significant 
increased risk of ESRD between persons who 
consumed more than two drinks per day compared 
to abstainers.7 According to a prospective study of 
Australian adults involving 6259 adults ≥25 years 
of age, without a history of alcohol dependence has 
shown a significant association between high 
amounts of alcohol consumption with ESRD.18
However, previous studies analysed western 
population only while in this study the alcohol 
intake were recorded from a multiracial population 
that consists of Malays, Chinese, and Indian. 
According to a study conducted on 562 consecutive 
attainders at an urban general practice, 70% of 
Chinese, 11% of Malays and 42% of Indians have 
used or are currently using alcohol and a vast 
majority of them were social drinkers.19 Thus, even 
though some of the subjects consume alcohol but 
the majority of them were social drinkers and the 
amount and frequency of alcohol intake were not as 
high as in western culture. It was may be due to 
Islamic belief for Malays that prohibit alcohol 
consumption and different culture practice for 
Chinese and Indians races compared to westerners.
CONCLUSIONS
This study revealed there was poor control of 
glycaemic level, blood pressure and lipid level 
among CKD patients with type 2 diabetes mellitus 
in UKMMC. Thus, the patients should be educated 
properly from dietary aspects and the importance of 
compliance to medications to achieve a better 
control of these parameters. Although the 
development of end-stage renal failure as the end 
spectrum of chronic kidney disease is deemed to be 
unpreventable, the optimization of the health status 
of the patients is helpful in delaying its progression, 
thereby prolonging their lifespan.
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Apart from that, this study supported the 
presence of relationship between blood pressure 
and low glomerular filtration rate (GFR), which 
had also been established in many other trials. 
Meanwhile, the necessity of modification of 
lifestyle such as smoking and alcohol cessation, 
besides dietary restriction of lipid and sugar intake 
should not be overlooked. Even though this study 
failed to reveal their role in hastening the 
deterioration of kidney function, this might be due 
to a number of limitations stated above.
Prevention is always better than cure. 
Hence, high risk population should be defined, so 
that intervention programmes can be targeted at 
them effectively. Health awareness campaign ought 
to be held in order to deliver knowledge to the 
public and aid in the control of the progression. 
Although aging is also correlated to the worsening 
of kidney function, other modifiable factors have to 
be emphasised and controlled to delay the onset of 
proteinuria and presence of other markers of kidney 
disease. Screening of high-risk groups might be 
needed so that treatment can be commenced 
immediately once a patient was diagnosed.
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